Literature DB >> 21432836

Citicoline: pharmacological and clinical review, 2010 update.

J J Secades1.   

Abstract

This review is based on the previous one published in 2006 -Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol 2006; 28 (Suppl B): S1-56-, incorporating the new references until now, having all the information available to facilitate the access to the informacion in one document. This review is focused on the main indications of the drug, as acute stroke and its sequelae, including the cognitive impairment, and traumatic brain injury and its sequelae. There are retrieved the most important experimental and clinical data in both indications.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21432836

Source DB:  PubMed          Journal:  Rev Neurol        ISSN： 0210-0010            Impact factor:   0.870


  28 in total

1.  Protective effects of citicoline on TNBS-induced experimental colitis in rats.

Authors:  Rauf Onur Ek; Mukadder Serter; Kemal Ergin; Serpil Cecen; Cengiz Unsal; Yuksel Yildiz; Mehmet D Bilgin
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline-caffeine beverage.

Authors:  Steven E Bruce; Kimberly B Werner; Brittany F Preston; Laurie M Baker
Journal:  Int J Food Sci Nutr       Date:  2014-07-21       Impact factor: 3.833

3.  Citicoline in severe traumatic brain injury: indications for improved outcome : A retrospective matched pair analysis from 14 Austrian trauma centers.

Authors:  Helmut Trimmel; Marek Majdan; Andrea Wodak; Guenther Herzer; Daniel Csomor; Alexandra Brazinova
Journal:  Wien Klin Wochenschr       Date:  2017-07-27       Impact factor: 1.704

4.  The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia Study.

Authors:  Alberto Castagna; Antonino Maria Cotroneo; Giovanni Ruotolo; Pietro Gareri
Journal:  Clin Drug Investig       Date:  2016-12       Impact factor: 2.859

Review 5.  A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury.

Authors:  Iman El Sayed; Adel Zaki; Akram M Fayed; Gihan M Shehata; Sherif Abdelmonem
Journal:  Neurosurg Rev       Date:  2016-08-18       Impact factor: 3.042

6.  Ghrelin Is Effective on Passive Avoidance Memory by Altering the Expression of NMDAR and HTR1a Genes in the Hippocampus of Male Wistar Rats.

Authors:  Vahideh Sahraiian; Homayoun Khazali
Journal:  Rep Biochem Mol Biol       Date:  2021-10

7.  Protective effect of CDP-choline on ischemia-reperfusion-induced myocardial tissue injury in rats.

Authors:  C Coskun; B Avci; M Yalcin; A Yermezler; M S Yilmaz; V Savci
Journal:  Ir J Med Sci       Date:  2013-11-29       Impact factor: 1.568

8.  Citicoline protects brain against closed head injury in rats through suppressing oxidative stress and calpain over-activation.

Authors:  Ke Qian; Yi Gu; Yumei Zhao; Zhenzong Li; Ming Sun
Journal:  Neurochem Res       Date:  2014-04-02       Impact factor: 3.996

9.  Retrospective and observational study to assess the efficacy of citicoline in elderly patients suffering from stupor related to complex geriatric syndrome.

Authors:  Salvatore Putignano; Pietro Gareri; Alberto Castagna; Giuliano Cerqua; Pasquale Cervera; Antonino Maria Cotroneo; Francesco Fiorillo; Rodolfo Grella; Roberto Grella; Roberto Lacava; Antonio Maddonni; Saverio Marino; Alice Pluderi; Daria Putignano; Filomena Rocca
Journal:  Clin Interv Aging       Date:  2012-05-10       Impact factor: 4.458

10.  Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study.

Authors:  Antonino Maria Cotroneo; Alberto Castagna; Salvatore Putignano; Roberto Lacava; Fausto Fantò; Francesco Monteleone; Filomena Rocca; Alba Malara; Pietro Gareri
Journal:  Clin Interv Aging       Date:  2013-02-05       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.